Emily A Sloan, MD,PhD| Pathology | MedStar Health
About me
Emily A. Sloan, MD, PhD, is the Associate Director of Neuropathology within the MedStar Comprehensive Brain Tumor Center and Department of Pathology at MedStar Georgetown University Hospital. As a diagnostic neuropathologist, her clinical focus is on diagnosis of diseases of the central nervous system and peripheral nervous system, with an emphasis on neoplastic disease and the grading and classification of CNS tumors. She is triple board certified in Neuropathology, Anatomic Pathology, and Clinical Pathology.
Dr. Sloan is a member of multiple societies including the American Association of Neuropathologists, College of American Pathologists, and United States and Canadian Academy of Pathology. She has published more than 25 basic science and translational research studies in peer-reviewed journals and takes part in national conferences to remain up to date on the rapidly evolving field of CNS tumor classification. With this knowledge, she integrates histopathologic tumor classification with comprehensive molecular testing, ensuring that her patients receive the best possible diagnostic care. Dr. Sloan also actively participates in education of residents, fellows, and medical students, receiving a teaching award for Resident Education. She earned her Ph.D in Microbiology, Immunology and Cancer Biology investigating the molecular genetics of the HIV virus in primary infections, with a particular focus on global health. She maintains a strong interest in infectious diseases and health equity.
Dr. Sloan’s main areas of clinical expertise include:
- Expert diagnostic services in neuro-oncology, epilepsy, nerve and muscle disorders, neurodegenerative diseases, and CNS infections
- Rapid intraoperative consultations
- Post-mortem neuropathologic brain examinations, including evaluation of neurodegenerative diseases, as well as general autopsy services
- Ancillary techniques including histochemistry, immunohistochemistry, ultrastructural evaluation, and molecular genetics for integrated tumor classification
Conditions and procedures
Conditions I treat
- Acoustic Neuroma
- Anaplastic Astrocytoma
- Anaplastic Ependymoma
- Arachnoid Cyst
- Benign Neoplasm Of Brain
- Brain And Spine Tumors
- Brain Neoplasms
- Cavernous Hemangioma
- Central Nervous System Abscess
- Central Nervous System Infection
- Central Nervous System Malignancy
- Central Nervous System Tumors
- Cerebral Anomalies
- Cerebral Hemorrhage
- Clivus Chondroma
- Demyelinating Disease
- Dural Based Tumor
- Embryonal Cell Tumors Of The Brain
- Embryonal Tumors
- Endodermal Sinus Tumor
- Ganglioneuroblastoma
- Genetic Disorders
- Glioblastoma Multiforme
- Leptomeningeal Carcinomatosis
- Malignant Brain Neoplasm
- Malignant Neoplasm Of Brain Stem
- Malignant Neoplasm Of The Spinal Cord
- Medulloepithelioma
- Meningioma
- Metastatic Brain Cancer
- Muscular Dystrophy
- Nasopharyngeal Angiofibroma
- Neuroendocrine Tumors
- Rhabdoid Tumor Predisposition Syndrome
- Spinal Cord Tumors
- Tuberous Sclerosis
- Turcot Syndrome
- Vertebral Hemangioma
- Von Hippel Lindau Disease
Procedures I perform
- Autopsy
- Brain Cancer Genomics
- Cancer Genetics
- Immunogenetics
- Next Generation Sequencing
- Tumor Pathology
- Whole Genome Sequencing
Insurance
MedStar Medical Group accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Medical Group, please call your insurance company.
-
List of insurance plans we accept
- Aetna Elect Choice/ EPO (Aetna Health Fund) Innovation Health: Network Only Plus
- Aetna Quality Point of Service (POS)
- Aetna Student Health Insurance
- Aetna Medicare Advantage HMO & PPO Plans
- CFBCBS BlueChoice HMO
- CFBCBS Blue Choice Opt Out Plus Open Access (POS)
- CFBCBS Maryland Point of Service Plan (MPOS)
- CFBCBS Maryland Indemnity or PPO
- CFBCBS (NCA) Indemnity
- CIGNA HMO & Network (HMO)
- CIGNA POS/Network POS
- Great-West Healthcare POS/CIGNA
- CIGNA Indemnity
- Coventry Health Care of Virginia
- Coventry of Delaware HMO/PPO
- First Health PPO
- FIRST HEALTH
- Tricare Prime
- Tricare for Life (Medicare Supplemental Plan)
- MedStar Family Choice - Maryland Health Choice
- MedStar Select (MedStar Associates' Plan)
- United Healthcare Select HMO - EPO/NPP
- United Healthcare Select Plus (POS)
- United Healthcare Choice Plus
- United Student Resources
- M.D. IPA (HMO)
- M.D. IPA Preferred (POS)
- Optimum Choice Preferred (POS) & OCI Direct (HMO)
- Mamsi Life & Health (Indem./PPO)
- Aetna Worker's Compensation Network
- Coventry Health Care National Network PPO
- United Healthcare Choice
- CIGNA HMO Open Access (OA)
- Network OA
- POS OA & OA Plus
- CIGNA EPO
- PPO and PPO Plus
- Choice Fund PPO
- CFBSBC Blue Preferred PPO
- HealthyBlue PPO
- CFBCBS Blue Choice Opt Out Open Access
- BlueChoice Open Access
- Aetna Traditional Choice (PPO)
- Innovation Health: Indemnity
- Aetna Open Choice (PPO)
- Innovation Health: PPO
- Aetna Managed Choice (POS)
- Innovation Health: POS Plus
- Aetna Elect Choice/ Open Access (POS)
- Innovation Health: Open Network Only Plus
- Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
- Innovation Health: POS
- Open HMO
- Opoen HMO Option
- Open EPO Plus
- Aetna Managed Choice Open Access (POS)
- Choice POS & Choice POS II
- Innovation Health: Open POS Plus
- Open POS II
- Aetna HMO
- Select HMO/HealthFund/Health Network
- Aetna Innovations: HMO & EPO Plus
- Blue Choice Advantage & Healthy Blue (HMO, POS)"
- CFBCBS EPO
- CFBCBS Federal Employee Program (Std/Basic PPO/Blue Focus)
- Kaiser MD Medicaid MCO
- Kaiser Permanente Flexible Choice POS
- Kaiser Permanente Medicare Plus (Medicare Supplemental Plan)
- Kaiser Permanente Select
- Kaiser Permanente Signature
- Kaiser Permanente Signature-Added Choice
- Kaiser PermanenteSelect-Added Choice
- Kaiser Virginia Premier
- Medicare Fee for Service
- Private Health Care Systems (PHCS) (PPO)
- UHC Community Plan of MD
- United Healthcare Options (PPO) (includes Empire PPO, GEHA, Compass Rose)"
- UnitedHealthcare and AARP Medicare Complete Plans/ UHC Group Medicare Advantage Plans HMO, POS, PPO"
- UnitedHealthcare Medicare Adv/Special Needs Plans
- Kaiser Permanente Medicare Advantage Signature and Select (aka Senior Advantage)"
Education
Board Certification: American Board of Pathology, Anatomic Pathology
Board Certification: American Board of Pathology, Clinical Pathology
Board Certification: American Board of Pathology, Neuropathology
Fellowship Program: University of California San Francisco (2020)
Residency Program: University of Virginia Hospitals (2018)
Medical School: University of Virginia School of Medicine (2014)
Awards
- Resident Teaching Award, MedStar Georgetown Department of Pathology (2022)
- Moore Award for best clinico-pathologic paper in neuropathology, American Association of Neuropathologists (AANP) (2020)
- O.T. Bailey-Helena Riggs Award, AANP Diagnostic Slide Session (2019)
Hospital affiliations
News and publications
- Sloan EA, Gupta R, Koelsche C, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Reddy A, Mueller S, Cho SJ, Horvai AE, Lee JC, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, von Deimling A, Chang SM, Berger MS, Solomon DA. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathol. 2022 Jul;32(4):e13037. doi: 10.1111/bpa.13037. Epub 2021 Nov 25. PMID: 34821426; PMCID: PMC9245938.
- Sloan EA, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Raffel C, Berger MS, Chang SM, Reddy A, Ramani B, Ferris SP, Lee JC, Hofmann JW, Cho SJ, Horvai AE, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, Solomon DA. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathol. 2021 Jul;31(4):e12918. doi: 10.1111/bpa.12918. Epub 2021 Jan 28. PMID: 33141488; PMCID: PMC8089120.
- Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, Samuel D, Brown M, Carmichael J, Lu R, Mirchia K, Sullivan DV, Pekmezci M, Tihan T, Bollen AW, Perry A, Banerjee A, Mueller S, Gupta N, Hervey-Jumper SL, Oberheim Bush NA, Daras M, Taylor JW, Butowski NA, de Groot J, Clarke JL, Raleigh DR, Costello JF, Phillips JJ, Reddy AT, Chang SM, Berger MS, Solomon DA. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol. 2022 Oct;144(4):747-765. doi: 10.1007/s00401-022-02478-5. Epub 2022 Aug 9. PMID: 35945463; PMCID: PMC9468105.
- Yeh J, Marks JA, Alzeer AH, Sloan EA, Varghese R, Paudel N, Reuss JE, Bergquist PJ, Liu SV, Kim C. Remarkable Intracranial Response to Sotorasib in a Patient With KRASG12C-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case Report. JTO Clin Res Rep. 2022 Nov 6;3(12):100428. doi: 10.1016/j.jtocrr.2022.100428. PMID: 36471683; PMCID: PMC9719091.
- Alonzo CJ, Burnsed JC, Sloan EA, Zanelli SA. A Term Infant with Encephalopathy and Severe Leukocytosis. Neoreviews. 2022 Aug 1;23(8):e579-e581. doi: 10.1542/neo.23-8-e579. PMID: 35909106.
- Mehta A, Khan F, Wagner C, Hashemzadeh T, Stemer A, Sloan EA, Mayson D, Amjad F. A Case of Neurosarcoid Presenting as Multiple Intraparenchymal Hemorrhages. Neurohospitalist. 2022 Jan;12(1):162-166. doi: 10.1177/19418744211029495. Epub 2021 Jun 30. PMID: 34950407; PMCID: PMC8689526.
- Pekmezci M, Morshed RA, Chunduru P, Pandian B, Young J, Villanueva-Meyer JE, Tihan T, Sloan EA, Aghi MK, Molinaro AM, Berger MS, Hervey-Jumper SL. Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology. Sci Rep. 2021 Jun 9;11(1):12162. doi: 10.1038/s41598-021-91648-8. PMID: 34108566; PMCID: PMC8190264.
- Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, M Chang S, Berger MS, Solomon DA, Perry A. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathol. 2020 Dec;140(6):907-917. doi: 10.1007/s00401-020-02221-y. Epub 2020 Sep 6. PMID: 32892244; PMCID: PMC7682537.
- Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, M Chang S, Berger MS, Solomon DA, Perry A. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma. Acta Neuropathol. 2020 Dec;140(6):907-917. doi: 10.1007/s00401-020-02221-y. Epub 2020 Sep 6. PMID: 32892244; PMCID: PMC7682537.
- Sloan EA, Sampognaro PJ, Junn JC, Chin C, Jacques L, Ramachandran PS, DeRisi JL, Wilson MR, Kriegstein AR, Bollen AW, Solomon DA, Margeta M, Engstrom JW. Neuroglial stem cell-derived inflammatory pseudotumor (n-SCIPT): clinicopathologic characterization of a novel lesion of the lumbosacral spinal cord and nerve roots following intrathecal allogeneic stem cell intervention. Acta Neuropathol. 2019 Dec;138(6):1103-1106. doi: 10.1007/s00401-019-02089-7. Epub 2019 Oct 28. PMID: 31659431; PMCID: PMC6858593.
- Sloan EA, Cooney T, Oberheim Bush NA, Buerki R, Taylor J, Clarke JL, Torkildson J, Kline C, Reddy A, Mueller S, Banerjee A, Butowski N, Chang S, Mummaneni PV, Chou D, Tan L, Theodosopoulos P, McDermott M, Berger M, Raffel C, Gupta N, Sun PP, Li Y, Shah V, Cha S, Braunstein S, Raleigh DR, Samuel D, Scharnhorst D, Fata C, Guo H, Moes G, Kim JYH, Koschmann C, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Pekmezci M, Phillips JJ, Tihan T, Bollen AW, Perry A, Solomon DA. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. Acta Neuropathol. 2019 Nov;138(5):877-881. doi: 10.1007/s00401-019-02072-2. Epub 2019 Sep 12. PMID: 31515627; PMCID: PMC6818961.
- Sloan EA, Hilz S, Gupta R, Cadwell C, Ramani B, Hofmann J, Kline CN, Banerjee A, Reddy A, Oberheim Bush NA, Chang S, Braunstein S, Chang EF, Raffel C, Gupta N, Sun PP, Kim JYH, Moes G, Alva E, Li R, Bruggers CS, Alashari M, Wetmore C, Garg S, Dishop M, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Phillips JJ, Pekmezci M, Tihan T, Bollen AW, Berger MS, Costello JF, Perry A, Solomon DA. Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features. Acta Neuropathol. 2020 May;139(5):953-957. doi: 10.1007/s00401-020-02144-8. Epub 2020 Mar 10. PMID: 32157385; PMCID: PMC7183424.